01 junio 2016

JACC. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

Marc P. Bonaca, MD, MPHa; Deepak L. Bhatt, MD, MPHa; Robert F. Storey, MDb; Ph. Gabriel Steg, MDc; Marc Cohen, MDd; Julia Kuder, MSa; Erica Goodrich, MSa; José C. Nicolau, MD, PhDe; Alexander Parkhomenko, MDf; José López-Sendón, MDg; Mikael Dellborg, MDh; Anthony Dalby, MDi; Jindřich Špinar, MDj; Philip Aylward, MDk; Ramón Corbalán, MDl; Maria Teresa B. Abola, MDm; Eva C. Jensen, MD, PhDn; Peter Held, MD, PhDn; Eugene Braunwald, MDa; Marc S. Sabatine, MD, MPHa

Background: Peripheral artery disease (PAD) is associated with heightened ischemic and bleeding risk in patients with prior myocardial infarction (MI).

01 mayo 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Association between health status and long-term mortality after percutaneous revascularization of peripheral artery disease

Matthew C. Bunte MD, MS1,2, John A. House MS1, John A. Spertus MD, MPH1,2, David J. Cohen MD, MSC1,2, Steven P. Marso MD3 andDavid M. Safley MD1,2,*

Objectives: To explore the association of health status change and long-term survival among patients with symptomatic peripheral artery disease (PAD).

01 mayo 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of long-term patency after endovascular therapy for superficial femoral artery occlusive disease between patients with and without hemodialysis

Junya Matsumi MD*, Kazuki Tobita MD, Koki Shishido MD, Shingo Mizuno MD, Futoshi Yamanaka MD, Masato Murakami MD, Yutaka Tanaka MD, Saeko Takahashi MD, Takeshi Akasaka MD andShigeru Saito MD, FACC

Objective: To compare long-term patency after endovascular therapy (EVT) for superficial femoral artery (SFA) occlusive disease between patients with hemodialysis (HD; HD+) and those without HD (HD−).

07 octubre 2015

CIRCULATION. Interventional Cardiology. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis. The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial

Hans Krankenberg, MD*; Thilo Tübler, MD*; Maja Ingwersen, DVM; Michael Schlüter, PhD; Dierk Scheinert, MD; Erwin Blessing, MD; Sebastian Sixt, MD; Arne Kieback, MD; Ulrich Beschorner, MD; Thomas Zeller, MD

Background: Drug-coated balloon angioplasty (DCBA) was shown to be superior to standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo superficial femoral artery disease. For in-stent restenosis, the benefit of DCBA over POBA remains uncertain.

01 febrero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Peripheral Vascular Disease. Femoropopliteal Artery Stent Thrombosis. Report From the Excellence in Peripheral Artery Disease Registry

Subhash Banerjee, MD, Karan Sarode, MA, Atif Mohammad, MD, Osvaldo Gigliotti, MD, Mirza S. Baig, MD, Shirling Tsai, MD, Nicolas W. Shammas, MD, Anand Prasad, MD, Mazen Abu-Fadel, MD, Andrew Klein, MD, Ehrin J. Armstrong, MD, Haekyung Jeon-Slaughter, PhD, Emmanouil S. Brilakis, MD and Deepak L. Bhatt, MD, MPH

Background: There are limited data on femoropopliteal artery stent thrombosis (ST), which is a serious adverse outcome of peripheral artery interventions.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Endovascular Repair of Acute and Chronic Aortic Type B Dissections. Main Factors Affecting Aortic Remodeling and Clinical Outcome

Fabrizio Fanelli, MD∗; Alessandro Cannavale, MD∗; Gerard J. O’Sullivan, MD†; Marianna Gazzetti, MD, PhD‡; Carlo Cirelli, MD∗; Pierleone Lucatelli, MD∗; Mariangela Santoni, MD∗; Carlo Catalano, MD∗

Objectives: The aim of this study was to assess factors influencing the clinical outcome and morphological changes of acute and chronic type B aortic dissection after thoracic endovascular aortic repair (TEVAR).

01 diciembre 2015

JACC. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions. 24-Month Results of IN.PACT SFA

John R. Laird, MD∗; Peter A. Schneider, MD†; Gunnar Tepe, MD‡; Marianne Brodmann, MD§; Thomas Zeller, MD‖; Christopher Metzger, MD¶; Prakash Krishnan, MD#; Dierk Scheinert, MD∗∗; Antonio Micari, MD, PhD††; David J. Cohen, MD, MSc‡‡; Hong Wang, MD, MPH§§; Melissa S. Hasenbank, PhD§§; Michael R. Jaff, DO‖‖

Background: Evidence from large, randomized, controlled peripheral artery disease trials reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the DCB showed favorable 1-year outcomes compared with conventional percutaneous transluminal angioplasty (PTA), yet durability of the treatment effect with DCBs remains unknown.

01 diciembre 2015

JACC. Renal Artery Stent Outcomes. Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient

Timothy P. Murphy, MD∗,†; Christopher J. Cooper, MD‡; Alan H. Matsumoto, MD§; Donald E. Cutlip, MD‖,¶; Karol M. Pencina, PhD‖; Kenneth Jamerson, MD#; Katherine R. Tuttle, MD∗∗,††; Joseph I. Shapiro, MD‡‡; Ralph D’Agostino, PhD‖,§§; Joseph Massaro, PhD‖,§§; William Henrich, MD‖‖; Lance D. Dworkin, MD∗,†

Background: Multiple randomized clinical trials comparing renal artery stent placement plus medical therapy with medical therapy alone have not shown any benefit of stent placement. However, debate continues whether patients with extreme pressure gradients, stenosis severity, or baseline blood pressure benefit from stent revascularization.

01 febrero 2016

JACC. Blood Oxygenation Level-Dependent CMR-Derived Measures in Critical Limb Ischemia and Changes With Revascularization

Adnan Bajwa, BSca; Roman Wesolowski, PhDb; Ashish Patel, PhDa; Prakash Saha, PhDa; Francesca Ludwinski, PhDa; Mohammed Ikram, PhDa; Mostafa Albayati, MBBS, BSca; Alberto Smith, PhDa; Eike Nagel, MD, PhDb,c; Bijan Modarai, PhDa

Background: Use of blood oxygenation level-dependent cardiovascular magnetic resonance (BOLD-CMR) to assess perfusion in the lower limb has been hampered by poor reproducibility and a failure to reliably detect post-revascularization improvements in patients with critical limb ischemia (CLI).

01 febrero 2016

JACC. Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index

Rafel Ramos, MD, PhDa,b,c,d; Maria García-Gil, MD, PhDa,b,d; Marc Comas-Cufí, MSca,b; Miquel Quesada, MDa,b,c,d; Jaume Marrugat, MD, PhDe,f; Roberto Elosua, MD, PhDd,e; Joan Sala, MD, PhDc,f; María Grau, MD, PhDe; Ruth Martí, PhDa,b,c; Anna Ponjoan, MPha,b,c; Lia Alves-Cabratosa, MDa,b; Jordi Blanch, MSca,b; Bonaventura Bolíbar, MD

Background: Evidence is lacking about the effectiveness of risk reduction interventions in patients with asymptomatic peripheral arterial disease.

01 febrero 2016

JACC. Nonsyndromic Thoracic Aortic Aneurysm and Dissection. Outcomes With Marfan Syndrome Versus Bicuspid Aortic Valve Aneurysm

Andrew G. Sherrah, BSc, MBBSa; Sarah Andvik, BMed, MDa; Denise van der Linde, MD, PhDb; Lucy Davies, MScc; Paul G. Bannon, PhDa,d; Ratnasari Padang, PhDa; Michael P. Vallely, PhDa,d; Michael K. Wilson, MBBSa,d; Anthony C. Keech, PhDb,c; Richmond W. Jeremy, PhDa

Background: Genetic aortopathy (GA) underlies thoracic aortic aneurysms (TAA) in younger adults. Comparative survival and predictors of outcomes in nonsyndromic TAA (NS-TAA) are incompletely defined compared to Marfan syndrome (MFS) and bicuspid aortic valve (BAV).

01 febrero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation

Noam Fink MD*, Amit Segev MD, Israel Barbash MD, Andrada Bogdan MD, Ashraf Hamdan MD, Israel Mazin MD, Elad Maor MD, PhD, Ilan Hay MD, Victor Guetta MD andPaul Fefer MD

Objective: To assess the rate of Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation (TAVI).

01 diciembre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Laser in infrapopliteal and popliteal stenosis 2 study (LIPS2): Long-term outcomes of laser-assisted balloon angioplasty versus balloon angioplasty for below knee peripheral arterial disease

Chatchawan Piyaskulkaew MD1, Kesav Parvataneni MD1, Hussein Ballout MD1, Susan Szpunar PhD1, Tarun Sharma MD1, Mohamed Almahmoud MD2, Thomas LaLonde MD1, Thomas Davis MD1, Rajendra H. Mehta MD3 andHiroshi Yamasaki MD1,*

Background: Laser-assisted balloon angioplasty (LABA) has been shown to be more effective in achieving angiographic success for treatment for below knee peripheral artery disease (PAD) compared with balloon angioplasty alone(BA). However, long-term outcomes of LABA compared with BA for popliteal and infrapopliteal PAD are unknown.

01 diciembre 2015

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Endovascular revascularization of a surgically ligated superficial femoral artery: A case report

Kalkidan Bishu MD, MS1,2 andEhrin J. Armstrong MD, MSC, MAS1,2,*

We present a case of a patient with left lower extremity ischemic rest pain who initially underwent surgical profundaplasty requiring ligation of his superficial femoral artery (SFA). The patient developed continued rest pain due to diffuse disease of his profunda and inadequate collaterals. Endovascular intervention was therefore performed to the oversewn SFA. Retrograde left SFA access was obtained and the origin of the SFA was recanalized with true lumen re-entry using an ultrasound guided re-entry catheter. Angioplasty was performed at the origin of the SFA and self-expanding stents were deployed in the proximal and mid left SFA. Hemostasis at the distal left SFA access site was obtained by balloon inflation at the access site and manual compression. This case illustrates the feasibility of endovascular repair of a ligated SFA. © 2015 Wiley Periodicals, Inc.

02 septiembre 2015

CIRCULATION. Cardiovascular Surgery. Risk of Rupture or Dissection in Descending Thoracic Aortic Aneurysm

Joon Bum Kim, MD, PhD; Kibeom Kim, BA; Mark E. Lindsay, MD, PhD; Thomas MacGillivray, MD; Eric M. Isselbacher, MD; Richard P. Cambria, MD; Thoralf M. Sundt III, MD

Background: Current practice guidelines recommend surgical repair of large thoracic aortic aneurysms to prevent fatal aortic dissection or rupture, but limited natural history data exist to support clinical criteria for timely intervention.